Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant

View source ↗

Summary

An observational study update examining adults with diabetic macular edema who have suboptimal response to anti-VEGF therapy and are treated with the dexamethas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: AbbVie | Conditions: Diabetic Macular Edema | Status: ACTIVE_NOT_RECRUITING